GLP-1RA

Clinical Advances in GLP-1 Receptor Target: First Step of STEP Series Study

by
Clinical Advances in GLP-1 Receptor Target: First Step of STEP Series Study

CK Note: The latest evidence from clinical trials supports the efficacy and tolerability of glucagon-like peptide-1 (GLP-1) receptor agonists as effective weight loss medications. Although initially developed as hypoglycemic agents for type 2 diabetes patients, research over the past 30 years has shown that GLP-1 receptor agonists can act in the central nervous system to … Read more

Overview of Semaglutide Tablets Safety Data

by
Overview of Semaglutide Tablets Safety Data

*For medical professionals only Editor’s Note Glucagon-like peptide-1 receptor agonists (GLP-1RA) have been used for nearly 20 years in the management of blood glucose in patients with type 2 diabetes (T2DM) since their launch. With the increasing evidence from research, the efficacy of some GLP-1RAs in effective glucose lowering, multiple metabolic improvements, and cardiovascular benefits … Read more